Search results
Rs 203.14 crore
- Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
People also ask
How did Fortis Healthcare perform in q4fy23?
How did Fortis Healthcare perform in the quarter?
What was Fortis Healthcare's EBITDA & dividend income in 2022?
What is Fortis Healthcare Limited?
Get Fortis Healthcare latest Key Financial Ratios, Financial Statements and Fortis Healthcare detailed profit and loss accounts.
- Fortis Health Stock Quote
Buy Fortis Healthcare; target of Rs 515: Prabhudas Lilladher...
- Earnings
Unicommerce Esolutions Q1 net profit up 31% YoY to Rs 3.5...
- Business
Find Latest Business News on Indian Economy,Top News on...
- Announcements
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of...
- Fortis Health Stock Quote
Aug 15, 2024 · Here is a summary of financial information of FORTIS HEALTHCARE LIMITED for the financial year ending on 31 March, 2022. Revenue / turnover of FORTIS HEALTHCARE LIMITED is Over INR 500 cr. Net worth of the company has decreased by -0.15 %. EBITDA of the company has increased by 313.50 %.
Hospital Business registers a healthy performance in Revenues and Margins. Strengthens presence in NCR with the acquisition of a potential 450 bed hospital in Manesar, Gurugram in FY24. Q4 FY24 Consolidated Revenues increase 8.7% to INR 1,786 Crs. Consolidated Operating EBITDA up 40.5% to INR 380 Crs, 21.3% Margin.
May 23, 2023 · Fortis Healthcare's Q4FY23 reported a net profit of Rs 138 crore, which was a YoY increase of 59% due to higher occupancy rates and an increase in surgical volumes. The hospital revenues increased by 29.7% and EBITDA margins increased by 80 basis points to 17.3 %.
- Viswanath Pilla
May 23, 2024 · Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
The revenue contribution from the Company’s key medical specialties viz. Oncology, Orthopaedics, Renal Sciences, Cardiac Sciences, Neurosciences and Gastroenterology to overall hospital revenues increased to 60.5% in Q2 FY23 from 56.9% in Q2 FY22.
Aug 6, 2024 · The healthcare provider reported net profit of Rs 124 crore in the corresponding quarter of the previous year. Revenue rose 12.2% YoY to Rs 1859 crore. The operating earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 25.5% YoY to Rs 343 crore.